Cite Filings / CPMV / 9999999995-21-000342

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Mosaic ImmunoEngineering Inc. Filed 2021-01-29 Acc 9999999995-21-000342

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2021-01-29 EFFECT Notice of Effectiveness
2021-01-29 4 Acting CSO acquired 2,212,122 shares (conversion)
2021-01-29 4 EVP, Chief Financial Officer acquired 1,641,252 shares (conversion)
2021-01-29 4 President and CEO acquired 1,641,252 shares (conversion)
2021-01-29 4 Director acquired 356,794 shares (conversion)
2021-01-25 CORRESP Correspondence Between Filers and SEC Staff
2008-01-11 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…